India Surgical Gloves Market, by Type (Latex, Neoprene, Polyisoprene and Nitrile), by Usage (Disposable Gloves and Reusable Gloves), and by End User (Hospitals, Clinics, Ambulatory Surgical Center and Others), is estimated to be valued at US$ 116.9 Mn in 2022 and is expected to exhibit a CAGR of 7.5% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Key trends in market include increasing government initiatives to remove ban on import and export of gloves, which are expected to drive growth of the India surgical gloves market over the forecast period. For instance, in October 2020, the Government of India removed export ban on nitrile or nitrile butadiene rubber (NBR) gloves used by medical professionals.
Increase in adoption of strategies like collaborations and acquisitions by the key players in the market are expected to drive the growth of the market. For instance, in January, Ansell Limited, which is an Australian company which manufactures protective industrial and medical gloves, announced that the company completed the acquisition of Primus brand and related assets that constitute the life science business belonging to Primus Gloves, an India-based manufacturer and marketer of gloves for life science and specialty medical sectors, and Sanrea Healthcare Products, a medical glove manufacturing company.
India Surgical Gloves Market – Impact of Coronavirus (COVID-19) Pandemic
During COVID-19 pandemic, demand for surgical gloves increased, which led to its increased production. However, manufacturers were struggling to meet the high demands. This led to the shortage of surgical gloves, in India. Moreover, governments of some countries eased the regulations on import-export duties, which were banned during the COVID-19 pandemic. Moreover, according to data published on March 2021, on National Library of Medicine, during COVID-19, demand for gloves has increased three times than normal situation in India.The COVID-19 pandemic has negatively impacted the global economy and in turn, the healthcare market. Quarantine, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending until the end of the second quarter of 2020. Moreover, theCOVID-19 pandemic has significantly affected clinical trials. Many trials have paused enrollment and researchers are facing multiple challenges associated with setting up remote visits, and performing laboratory, and other study assessments. In 2020, Amway India, a marketing company, took an initiative under its COVID-19 relief programme to provide personal protective equipment such as gloves, gowns, masks, etc. to frontline workers through its NGO